<?xml version="1.0" encoding="UTF-8"?>
<p>As the epidemic of leptospirosis was confirmed nationwide in the fall of 1984, health authorities subsequently discussed prevention and management strategies; systematic research on clinical microbiology of leptospirosis in the Korea (determination of the causative serovars, major serogroups responding to patient sera, regional statistics on incidence and prevalence, and clinical-epidemiological characteristics), animal reservoirs (wild rodents and domestic animals) and routes of transmission, investigation of antibody titer in residents (seropositivity rate and epidemiological investigation through surveys), and development of serological diagnosis (improved passive hemagglutination). Vaccine development was also planned for 2 years from August 1985. With support by the Ministry of Science and Technology and cooperation, all these works were actively performed in collaboration with hospitals across the country; the findings of these research efforts were described in detail in reports from the KNIH [
 <xref rid="B25" ref-type="bibr">25</xref>
 <xref rid="B47" ref-type="bibr">47</xref>].
</p>
